glp 1 with kaiser insurance Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society What you need to know
Description
Nausea, vomiting, diarrhea, and reduced appetite typically occur during dose escalation
Kostrowicki J
Two studies found GLP-1s were associated with improvement in depressive symptoms and two other studies tied GLP-1s to an improvement in alcohol use disorder among people with obesity
Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations
While participants continued background medications such as metformin, they were randomized to receive a 2-mg dose of exenatide once weekly or a 1.8-mg dose of daily liraglutide
